NeueHealth, Inc. Income Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of income (loss)

In millions of USD; shares in millions, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue:
Premium revenue
Capitated revenue
Service revenue
Total revenue
Investment income (loss)
ACO REACH revenue
Investment income
Total revenue
Operating expenses:
Operating costs
Medical costs
Operating costs (including gain on disposal of $1,185 and $0, respectively)
Bad debt expense
Restructuring charges
Goodwill impairment
Intangible assets impairment
Depreciation and amortization
Total operating expenses
Operating loss
Other income
Interest expense
Warrant expense
Gain on troubled debt restructuring
Loss from continuing operations before income taxes
Income tax expense (benefit)
Net loss from continuing operations
Gain (Loss) from discontinued operations, net of tax (including gain on disposal of $66,201 and $0, respectively) (Note 19)
Net loss
Net earnings attributable to noncontrolling interests
Net loss attributable to Bright Health Group, Inc. common shareholders
Net (income) loss from continuing operations attributable to noncontrolling interests
Less: Preferred Stock Dividends Accrued
Series A preferred stock dividend accrued
Series B preferred stock dividend accrued
Series A and B preferred stock dividend accrued
Series A preferred stock dividend accrued
Series B preferred stock dividend accrued
Net loss attributable to NeueHealth, Inc. common shareholders
Basic and diluted (loss) income per share attributable to NeueHealth, Inc. common shareholders
Continuing operations, basic (in dollars per share)
Continuing operations, diluted (in dollars per share)
Discontinued operations, basic (in dollars per share)
Discontinued operations, diluted (in dollars per share)
Basic loss per share (in dollars per share)
Diluted loss per share (in dollars per share)
Basic weighted-average common shares outstanding (in shares)
Diluted weighted-average common shares outstanding (in shares)

Comments